Filters
The new Product Liability Directive: three life sciences priorities before the 2026 deadline
The new EU Product Liability Directive applies to products placed on the market after 9 December 2026. Three changes call for decisions by life sciences companies now: software and AI as products, an eased burden of proof, and disclosure of internal evidence.
3 of 9 Insights
Poland’s new AI systems act: a regulator and practical tools
Poland’s new AI systems act builds the national framework for the EU AI Act. A new regulator is introduced, alongside two practical tools.
9 of 9 Insights
Greenwashing in the Spotlight: The Polish Consumer Protection Authority Intensifies Scrutiny of Environmental Claims
Proposed Amendments to the EU Medical Device Regulation
A European Perspective #1 | The Commission’s proposed MDR/IVDR reform introduces substantial changes to certification, classification and compliance frameworks. Medical device companies should assess potential im-pacts early and prepare for a shifting regulatory landscape.
2 of 9 Insights
CJEU Ruling Reshapes Poland’s Pharmacy Advertising Rules
A European Perspective #1 | POLAND | The CJEU has found Poland’s prohibition on pharmacy advertising incompatible with EU law, effectively rendering the current provision unenforceable. Companies should monitor upcoming legislative changes and reassess promotional strategies in the interim.
9 of 9 Insights
How far does DORA reach? EIOPA draws the line between financial and non-financial activities
Preliminary injunctions in Poland
Comparison of national measures to protect the supply of medicines and medical devices
Our international team has developed a practical guide that allows users to navigate different European jurisdictions, identifying medicines subject to supply restrictions, and understand manufacturers' obligations during shortages or product withdrawals.
5 of 5 Insights
Work/Life - international employment news update
